Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


2nd Annual Congress of the European Society for Translational Medicine & Global Network Conference on Translational Medicine (EUSTM-2014)

22 Sep 2014 - 25 Sep 2014 - Vienna, Austria



Bookmark and Share


EUSTM-2014 unites world leaders and experts from industry, academia, research institutions, service providers, SMEs, regulatory agencies, policy makers, and governments to discuss translational approaches and tools designed to accelerate research and develop novel diagnostics and therapeutics thereby reducing high cost budgets and attrition rates. Moreover, EUSTM Expert Panels will discuss and showcase latest developments in specific areas of disease modeling, biomarkers, orphan/rare diseases, clinical epidemiology, novel diagnostics, public health, data management, omics applications and vaccine research. SPECIAL FEATURES: · High Profile Speakers and Panelists including FDA, EMA & NASA · Global Stakeholders and Key Opinion Leaders (KOLs) · Scientific Sessions · Panel Discussions · Featured Symposium - Bexsero (Novartis Vaccines) · New Horizon in Translational Medicine (NHTM) Journal Inauguration Ceremony · Posters Session KEY TOPICS AND THEMES: · Translating Novel Pathophysiological Findings into Therapeutics Developments · New Horizons in Biomarkers & Novel Diagnostics · Novel findings & Updates in Omics Sciences & Data Management · Diseases Modelling: Novel findings & Updates · New Horizons in Vaccine Adjuvants · New Horizons in Orphan Diseases R&D PANEL DISCUSSIONS/SYMPOSIA · Translational approaches to speed up therapeutics developments · Current advancements in modern diagnostic techniques & instrumentations · New Horizons in Orphan Diseases R&D · Disease Modelling- Current situation and future · New Horizons in Vaccine Adjuvants · Emerging role of Microwave Imaging Technology (by EU Cost Action TD1301) FEATURED SPEAKERS: · Elizabeth M. Sutkowski Chief, Regulatory Review Branch 3, DVRPA / OVRR / CBER / FDA (Rockville, Maryland) · Lesley Greene Vice Chair, Committee for Orphan Medicinal Products (COMP), European Medicines Agency (EMA) · Thomas J. Goodwin NASA / Johnson Space Center (Houston, USA) · Sohail Ahmed Global Head of Clinical Sciences, Novartis Vaccines (Italy) · Raffaele Baffa Head of Translational Sciences, ESI, Global BioTherapeutics, SANOFI (Cambridge, USA) · Dimitri Azar Dean, College of Medicine, University of Illinois at Chicago (Chicago, USA) · Giuseppe del Giudice Global Head Translational Medicine, Novartis Vaccines · Joel Haspel Director Product Strategy, Healthcare EMEA, Oracle Health Sciences · Nicolò Manaresi Founder & CSO, Silicon Biosystems, (Bologna Area, Italy) · Nicholas J. Sarlis Vice President & Head of Medical Affairs Incyte Corporation (Philadelphia, USA) WHO WILL SHOWCASE THEIR SERVICES AND PRODUCTS: The conference represents a unique opportunity to showcase and exhibit services & products for following types of companies: - Pharma and biotech - CROs - IT Applications & Software companies - Medtech & medical instruments companies - Molecular Biology & Biochemistry laboratory reagents & services providers - Genomics, Proteomics & Metabolomics services providers - Discover & preclinical services providers - Biomarkers services providers - Data management companies - Clinical services providers - Consultancy firms For more information on sponsorship & exhibition opportunities, please contact: Ms Sandra Oberhuber Event Manager EUSTM-2014 EUSTM Vienna, Austria. sandra.oberhuber@eutranslationalmedicine.org www.eutranslationalmedicine.org/eustm-2014 Phone: +43 1 8923 562 Fax: +43 1 8923 562 For conference related inquiries, please contact us at: eustm-2014@eutranslationalmedicine.org

Further information
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Allen Institute Releases Gene Edited Human Stem Cell Lines
The Allen Cell Collection, a publicly available collection of gene edited pluripotent stem cells, has been made available by the Allen Institute.
Designer Cell Fate Switches Could Streamline Stem Cell Biology
Researchers develop new method of reprogramming cells between cell types in a more efficient way than before.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Defining the Immortality of Stem Cells
Researchers defined the mechanisms underlying increased protein quality control of pluripotent stem cells.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
Stem Cells Police Themselves to Reduce Scarring
Scientists have discovered stem cells in muscle fibers change gene expressions to respond to injury.
Regenerating Diseased Hearts
Researchers from the University of Otago have probed the potential of adult stem cell types to repair diseased hearts.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!